Skip to main content

NeuroMusculoskeletal Institute

Research and Grants

Physicians and researchers at the NMI are deeply involved in investigations and clinical trials that target advancements in pain management. Most of our patient population has a long-standing relationship with our practice, offering us the abililty to easily connect a large, diverse population to clinical trials.

We work closely with RowanSOM's Clinical Trials Department, which is conveniently located in the same building. The Clinical Trials Department acts as an in-house contract research organization, providing 24-hour support from a nursing staff and departmental coordinator.

Below you will find an article on the NMI's education and training efforts to combat the opioid overdose crisis; followed by access to the RowanSOM—NJ Cares—NJ DCA New Jersey Opioid Medical Education Program live webinar and enduring recorded course series, including our most recent course on prescribing medication-assisted treatment in the era of COVID–19; the New Jersey Opioid Medical Education Program Naloxone Distribution and Training Programs Guide for the era of COVID–19; the New Jersey Opioid Medical Education Program COVID–19 Response Guide; and lastly, a collection of Dr. Jermyn's research efforts including clinical grants, clinical research grants, and clinical trials.

Please visit Continuing Medical Education at RowanSOM for information pertaining to additional training courses, including the HRSA Opioid Dentistry Education Program enduring recorded course series on best practices in opioid prescribing, pain management strategies, and referral to medication-assisted treatment; and the SAMHSA naloxone co-prescribing enduring recorded course.

"The reality is that these training and mentorship programs allow us to train hundreds of people to do what we do. We will help lead the initiative that will save lives in a much bigger and better way." —Dr. Jermyn

New Jersey Opioid Medical Education Program

A standardized, evidence-based opioid addiction prevention curriculum

Module 1: Best Practices in Opioid Treatment and Management

For physicians, physician assistants, dentists, podiatrists, optometrists, certified nurse midwives, and advanced practice nurses

Training on New Jersey opioid prescribing and guidelines 

Enduring Recorded Course: Registration now open

Available Credit for Physicians: 1 AOA Category 1-B credit and 1 AMA PRA Category 1 credit™

Available Credit for Other Listed Health Care Professionals: This enduring recorded course satisfies the statutory mandate that physician assistants, dentists, podiatrists, optometrists, certified nurse midwives, and nurses obtain one credit in continuing education programs concerning prescription opioid drugs as a condition of licensure renewal. Upon successful completion of the enduring recorded course, participants will receive a certificate of completion, and should retain it in accordance with their relevant licensing board's regulations.

 

Module 5: Screening Methodology and Minimizing the Risk of Overdose

For physicians, physician assistants, podiatrists, certified nurse midwives, advanced practice nurses, registered nurses, psychologists, marriage and family therapists, social workers, and professional counselors

Screening methodology, naloxone co-prescribing, and harm reduction strategies

Enduring Recorded Course: Registration now open

Available Credit for Physicians: 1 AOA Category 1-B credit and 1 AMA PRA Category 1 credit™

Available Credit for Other Listed Health Care Professionals: This enduring recorded course satisfies the statutory mandate that physician assistants, podiatrists, certified nurse midwives, nurses, psychologists, social workers, professional counselors, and marriage and family therapists obtain one credit in continuing education programs concerning prescription opioid drugs as a condition of licensure renewal. Upon successful completion of the enduring recorded course, participants will receive a certificate of completion, and should retain it in accordance with their relevant licensing board's regulations.

 

Module 6: Comprehensive Review of Medication-Assisted Treatment (MAT) for Opioid Use Disorder (OUD) in the Era of COVID–19

For physicians, physician assistants, podiatrists, certified nurse midwives, advanced practice nurses, psychologists, marriage and family therapists, social workers, and professional counselors

The effectiveness of MAT in treating OUD in opioid treatment programs (OTPs), outpatient settings, and emergency room settings

Enduring Recorded Course: Registration now open

Available Credit for Physicians: 1 AOA Category 1-B credit and 1 AMA PRA Category 1 credit™

Available Credit for Other Listed Health Care Professionals: This enduring recorded course satisfies the statutory mandate that physician assistants, podiatrists, certified nurse midwives, nurses, psychologists, social workers, professional counselors, and marriage and family therapists obtain one credit in continuing education programs concerning prescription opioid drugs as a condition of licensure renewal. Upon successful completion of the enduring recorded course, participants will receive a certificate of completion, and should retain it in accordance with their relevant licensing board's regulations.

Module 2: The Role of Pharmacists in Addressing New Jersey's Opioid Crisis

Using the New Jersey Prescription Monitoring Program (NJ PMP) and professional judgment to halt abuse and diversion; counseling patients on the proper use and disposal of opioid prescriptions

Enduring Recorded Course: Registration now open

Available Credit for Pharmacists: This enduring recorded course satisfies the statutory mandate that licensed pharmacists obtain one credit in continuing education programs concerning prescription opioid drugs as a condition of licensure renewal. Upon successful completion of the enduring recorded course, participants will receive a certificate of completion, and should retain it in accordance with the New Jersey Board of Pharmacy's regulations.

Module 3: Opioid Addiction Prevention Training for New Jersey Mental Health Professionals

For psychologists, marriage and family therapists, social workers, and professional counselors

Training for New Jersey mental health professionals on available treatments for opioid use disorder (OUD), and support to be provided during treatment and recovery

Enduring Recorded Course: Registration now open

Available Credit for Psychologists, Marriage and Family Therapists, Social Workers, and Professional Counselors: This enduring recorded course satisfies the statutory mandate that mental health professionals obtain one credit of continuing education on prescription opioid-related topics as a condition of licensure renewal. Upon successful completion of the enduring recorded course, participants will receive a certificate of completion, and should retain it in accordance with their relevant licensing board's regulations.

 

Module 5: Screening Methodology and Minimizing the Risk of Overdose

For physicians, physician assistants, podiatrists, certified nurse midwives, advanced practice nurses, registered nurses, psychologists, marriage and family therapists, social workers, and professional counselors

Screening methodology, naloxone co-prescribing, and harm reduction strategies

Enduring Recorded Course: Registration now open

Available Credit for Physicians: 1 AOA Category 1-B credit and 1 AMA PRA Category 1 credit™

Available Credit for Other Listed Health Care Professionals: This enduring recorded course satisfies the statutory mandate that physician assistants, podiatrists, certified nurse midwives, nurses, psychologists, social workers, professional counselors, and marriage and family therapists obtain one credit in continuing education programs concerning prescription opioid drugs as a condition of licensure renewal. Upon successful completion of the enduring recorded course, participants will receive a certificate of completion, and should retain it in accordance with their relevant licensing board's regulations.

 

Module 6: Comprehensive Review of Medication-Assisted Treatment (MAT) for Opioid Use Disorder (OUD) in the Era of COVID–19

For physicians, physician assistants, podiatrists, certified nurse midwives, advanced practice nurses, psychologists, marriage and family therapists, social workers, and professional counselors

The effectiveness of MAT in treating OUD in opioid treatment programs (OTPs), outpatient settings, and emergency room settings

Enduring Recorded Course: Registration now open

Available Credit for Physicians: 1 AOA Category 1-B credit and 1 AMA PRA Category 1 credit™

Available Credit for Other Listed Health Care Professionals: This enduring recorded course satisfies the statutory mandate that physician assistants, podiatrists, certified nurse midwives, nurses, psychologists, social workers, professional counselors, and marriage and family therapists obtain one credit in continuing education programs concerning prescription opioid drugs as a condition of licensure renewal. Upon successful completion of the enduring recorded course, participants will receive a certificate of completion, and should retain it in accordance with their relevant licensing board's regulations.

Module 1: Best Practices in Opioid Treatment and Management

For physicians, physician assistants, dentists, podiatrists, optometrists, certified nurse midwives, and advanced practice nurses

Training on New Jersey opioid prescribing and guidelines 

Enduring Recorded Course: Registration now open

Available Credit for Physicians: 1 AOA Category 1-B credit and 1 AMA PRA Category 1 credit™

Available Credit for Other Listed Health Care Professionals: This enduring recorded course satisfies the statutory mandate that physician assistants, dentists, podiatrists, optometrists, certified nurse midwives, and nurses obtain one credit in continuing education programs concerning prescription opioid drugs as a condition of licensure renewal. Upon successful completion of the enduring recorded course, participants will receive a certificate of completion, and should retain it in accordance with their relevant licensing board's regulations.

 

Module 4: Opioid Addiction Prevention Training for New Jersey Nurses and Athletic Trainers

For licensed practical nurses, registered nurses, and athletic trainers

Training for nurses and athletic trainers who care for patients taking opioid prescriptions

Enduring Recorded Course: Registration now open

Available Credit for Nurses, and Athletic Trainers: This enduring recorded course satisfies the statutory mandate that nurses and athletic trainers obtain one credit in continuing education programs concerning prescription opioid drugs as a condition of licensure renewal. Upon successful completion of the enduring recorded course, participants will receive a certificate of completion, and should retain it in accordance with their relevant licensing board's regulations.

 

Module 5: Screening Methodology and Minimizing the Risk of Overdose

For physicians, physician assistants, podiatrists, certified nurse midwives, advanced practice nurses, registered nurses, psychologists, marriage and family therapists, social workers, and professional counselors

Screening methodology, naloxone co-prescribing, and harm reduction strategies

Enduring Recorded Course: Registration now open

Available Credit for Physicians: 1 AOA Category 1-B credit and 1 AMA PRA Category 1 credit™

Available Credit for Other Listed Health Care Professionals: This enduring recorded course satisfies the statutory mandate that physician assistants, podiatrists, certified nurse midwives, nurses, psychologists, social workers, professional counselors, and marriage and family therapists obtain one credit in continuing education programs concerning prescription opioid drugs as a condition of licensure renewal. Upon successful completion of the enduring recorded course, participants will receive a certificate of completion, and should retain it in accordance with their relevant licensing board's regulations.

 

Module 6: Comprehensive Review of Medication-Assisted Treatment (MAT) for Opioid Use Disorder (OUD) in the Era of COVID–19

For physicians, physician assistants, podiatrists, certified nurse midwives, advanced practice nurses, psychologists, marriage and family therapists, social workers, and professional counselors

The effectiveness of MAT in treating OUD in opioid treatment programs (OTPs), outpatient settings, and emergency room settings

Enduring Recorded Course: Registration now open

Available Credit for Physicians: 1 AOA Category 1-B credit and 1 AMA PRA Category 1 credit™

Available Credit for Other Listed Health Care Professionals: This enduring recorded course satisfies the statutory mandate that physician assistants, podiatrists, certified nurse midwives, nurses, psychologists, social workers, professional counselors, and marriage and family therapists obtain one credit in continuing education programs concerning prescription opioid drugs as a condition of licensure renewal. Upon successful completion of the enduring recorded course, participants will receive a certificate of completion, and should retain it in accordance with their relevant licensing board's regulations.

Module 4: Opioid Addiction Prevention Training for New Jersey Nurses and Athletic Trainers

Training for nurses and athletic trainers who care for patients taking opioid prescriptions

Enduring Recorded Course: Registration now open

Available Credit for Nurses, and Athletic Trainers: This enduring recorded course satisfies the statutory mandate that nurses and athletic trainers obtain one credit in continuing education programs concerning prescription opioid drugs as a condition of licensure renewal. Upon successful completion of the enduring recorded course, participants will receive a certificate of completion, and should retain it in accordance with their relevant licensing board's regulations.

All participants who register for and complete a listed course will receive access to the New Jersey Opioid Medical Education Program Naloxone Distribution and Training Programs Guide. This comprehensive county-by-county guide, available in interactive and print formats for health care professional reference and patient education, includes pharmacies who dispense NARCAN® (naloxone hydrochloride) Nasal Spray and the recent FDA-approved generic naloxone hydrochloride nasal spray (utilizing standing orders, and via prescription). It also includes virtual trainings in the era of COVID–19 on how and when to use naloxone nasal spray.

This guide was a special research project developed in Spring 2020 as part of Module 5: Screening Methodology and Minimizing the Risk of Overdose. RowanSOM NMI staff, interns, and medical students contributed to the project. All listed pharmacies were telephonically verified with each location's licensed pharmacists, pharmacy technicians, or pharmacy assistants.

This project will remain continually updated.

All participants who register for and complete Module 6 will receive access to the New Jersey Opioid Medical Education Program COVID–19 Response Guide. This comprehensive guide, available in interactive format for health care professional reference, includes changes to health care policies and practices with a focus on prescribing and telemedicine; harm reduction strategies for patients with opioid use disorder; considerations for special populations including individuals experiencing homelessness; supporting and protecting minority communities, with a focus on trauma-informed and culturally competent patient care; and guidance from specialty organizations.

This guide was a special research project developed in Spring 2020 as part of Module 6: Comprehensive Review of Medication-Assisted Treatment (MAT) for Opioid Use Disorder (OUD) in the Era of COVID–19. RowanSOM NMI staff, interns, and medical students contributed to the project. 

This project will remain continually updated.

For questions pertaining to the New Jersey Licensing Boards; for questions and/or feedback pertaining to module content; and to discuss additions, edits, or feedback to the Naloxone Distribution and Training Programs Guide, and COVID–19 Response Guide, please contact Patricia Fortunato, RowanSOM NMI Content Manager/Program Manager at fortun83@rowan.edu

For questions pertaining to AOA and ACCME CME credits, please contact Tara Shontz, RowanSOM Program Coordinator at cme@rowan.edu

The below slides are a preview of our Module 6: Comprehensive Review of Medication-Assisted Treatment (MAT) for Opioid Use Disorder (OUD) in the Era of COVID–19. Our Module 6 preview information is also available in PDF format.

Research Efforts of Dr. Jermyn

Co-Director, Enhancing First Responder Access to Overdose Treatment in Atlantic County, New Jersey, $2,000,000 over four years, September 2019.

Director, Minority AIDS Initiative for High Risk Men of New Jersey, $2,500,000 over five years, August 2019.

Director, the New Jersey Opioid Medical Education Program (NJ–OMEP,) $941,582.31 over one year, April 2019.

Co–Director, Southern New Jersey Medication Assisted Treatment Center of Excellence (SNJ–MATrx–COE), $2,000,000 over one year, March 2019.

Co–Director, Buprenorphine Training Course, SAMHSA, $1,000,000 over one year, March 2019.

Director, A Naloxone Training Curriculum for Patients with Opiate Use Disorders to Prevent Fatal Overdose, New Jersey Health Foundation, Grant #PC 46–19, $35,000 over one year, February 2019.

Director, New Jersey Collaborative to Improve Access to Overdose Treatment, SAMHSA, $923,340 over five years, August 2018.

Director, Opioid Education for Oral Health Workforce and Dental Students Program, HRSA, $500,000 over five years, July 2018.

Director, American Osteopathic Association Cost Effectiveness of OMT, $340,468 over two years, May 2018.

Director, New Jersey Opioid Medical Education Program (STORI GRANT), $219,561 over two years, January 2018.

Director, New Jersey Geriatrics Workforce Enhancement Program—Opioid Supplemental Funding, July 1, 2018.

Director, Swedish Lottery Award, $100,000 for a music therapy program, ongoing.